BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 14639612)

  • 1. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.
    Baay MF; Smits E; Tjalma WA; Lardon F; Weyler J; Van Royen P; Van Marck EA; Vermorken JB
    Int J Cancer; 2004 Jan; 108(2):258-61. PubMed ID: 14639612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical human papillomavirus screening among older women.
    Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
    Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes.
    Beerens E; Van Renterghem L; Praet M; Sturtewagen Y; Weyers S; Temmerman M; Depypere H; Claeys P; Cuvelier CA
    Cytopathology; 2005 Aug; 16(4):199-205. PubMed ID: 16048506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
    Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
    J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi Province, China].
    Shen YH; Chen F; Huang MN; Liu B; Wang XX; Zhao FH; Li SM; Li N; Wu LY; Rong SD; Zhang WH; Ren SD; Huang RD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):381-5. PubMed ID: 12974078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
    Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
    Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
    Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.
    Hammer A; Mejlgaard E; Gravitt P; Høgdall E; Christiansen P; Steiniche T; Blaakaer J
    Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1262-8. PubMed ID: 26300424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
    Thomas JO; Herrero R; Omigbodun AA; Ojemakinde K; Ajayi IO; Fawole A; Oladepo O; Smith JS; Arslan A; Muñoz N; Snijders PJ; Meijer CJ; Franceschi S
    Br J Cancer; 2004 Feb; 90(3):638-45. PubMed ID: 14760378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.